{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:01:41Z","timestamp":1789394501340,"version":"build-2803163510"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jad.2014.06.023","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T14:15:20Z","timestamp":1403187320000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Bipolar disorder and gambling disorder comorbidity: Current evidence and implications for pharmacological treatment"],"prefix":"10.1016","volume":"167","author":[{"given":"Marco","family":"Di Nicola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"De Risio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pettorruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"De Crescenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Swierkosz-Lenart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Camardese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Giannantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2014.06.023_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2174\/138161211796150774","article-title":"Psychopharmacological treatment in pathological gambling: a critical review","volume":"17","author":"Achab","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2014.06.023_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2011.01.018","article-title":"Trait-related decision-making impairment in the three phases of bipolar disorder","volume":"70","author":"Adida","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00131746-200609000-00005","article-title":"Risperidone in cocaine-dependent patients with comorbid psychiatric disorders","volume":"12","author":"Albanese","year":"2006","journal-title":"J. Psychiatry Pract."},{"key":"10.1016\/j.jad.2014.06.023_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/jcp.0b013e3181602fd4","article-title":"A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence","volume":"28","author":"Anton","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jad.2014.06.023_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1037\/a0026367","article-title":"Methods of assessing craving to gamble: a narrative review","volume":"26","author":"Ashrafioun","year":"2012","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib7","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neubiorev.2008.05.019","article-title":"Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review","volume":"32","author":"Balanz\u00e1-Mart\u00ednez","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2014.06.023_bib8","first-page":"38","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders","volume":"24","author":"Beaulieu","year":"2012","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/15622975.2011.560964","article-title":"A double-blind, placebo-controlled trial of topiramate for pathological gambling","volume":"14","author":"Berlin","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of Bupropion in the treatment of pathological gambling","volume":"24","author":"Black","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","article-title":"Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study","volume":"27","author":"Black","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/wnf.0b013e31803d357f","article-title":"An open-label trial of escitalopram in the treatment of pathological gambling","volume":"30","author":"Black","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2008.02.013","article-title":"Extended release carbamazepine in the treatment of pathological gambling: an open-label study","volume":"32","author":"Black","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib15","first-page":"250","article-title":"An open-label trial of acamprosate in the treatment of pathological gambling","volume":"23","author":"Black","year":"2011","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.psychres.2008.04.023","article-title":"A pilot study of impulsivity and compulsivity in pathological gambling","volume":"167","author":"Blanco","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pnpbp.2006.11.006","article-title":"Gabapentin\u2019s acute effect on mood profile: a controlled study on patients with alcohol withdrawal","volume":"31","author":"Bonnet","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.7.1.9","article-title":"Spectrum of effectiveness of valproate in neuropsychiatry","volume":"7","author":"Bowden","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2014.06.023_bib19","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1517\/14656566.2012.741590","article-title":"Lamotrigine (Lamictal IR) for the treatment of bipolar disorder","volume":"13","author":"Bowden","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jad.2014.06.023_bib20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v66n0613","article-title":"Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole","volume":"66","author":"Brown","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4088\/JCP.v69n0502","article-title":"A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders","volume":"69","author":"Brown","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1530-0277.2009.01024.x","article-title":"A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence","volume":"33","author":"Brown","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.jad.2014.06.023_bib23","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2012.90","article-title":"A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence","volume":"37","author":"Brown","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Nauropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib25","first-page":"321","article-title":"Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive\u2013compulsive disorder: is response to treatment predictable?","volume":"27","author":"Carey","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib26","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/npp.2012.142","article-title":"The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T 1H-MRS study","volume":"37","author":"Cai","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychires.2013.12.006","article-title":"Imaging studies on dopamine transporter and depression: a review of literature and suggestions for future research","volume":"51","author":"Camardese","year":"2014","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2014.06.023_bib29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/aje\/kwr017","article-title":"Disordered (pathologic or problem) gambling and axis I psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"173","author":"Chou","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jad.2014.06.023_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/157488611794480016","article-title":"Aripiprazole-induced pathological gambling: a report of 3 cases","volume":"6","author":"Cohen","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.jad.2014.06.023_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","article-title":"A study of the dopamine D2 receptor gene in pathological gambling","volume":"6","author":"Comings","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jad.2014.06.023_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/070674370505000404","article-title":"A national survey of gambling problems in Canada","volume":"50","author":"Cox","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v10n04_02","article-title":"Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions","volume":"10","author":"Crosby","year":"1991","journal-title":"J. Addict. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/mpr.273","article-title":"Towards DSM-5: considering other withdrawal-like symptoms of pathological gambling disorder","volume":"18","author":"Cunningham-Williams","year":"2009","journal-title":"Int. J. Methods. Psychiatr. Res."},{"key":"10.1016\/j.jad.2014.06.023_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study","volume":"28","author":"Dannon","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study","volume":"25","author":"Dannon","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fpsyt.2011.00033","article-title":"Acamprosate and Baclofen were not effective in the treatment of pathological gambling: preliminary blind rater comparison study","volume":"2","author":"Dannon","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/npp.2008.175","article-title":"Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers","volume":"34","author":"de Ruiter","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1017\/S109285290001957X","article-title":"The impact of comorbidity on the management of pathological gambling","volume":"10","author":"Dell\u2019Osso","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2014.06.023_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4088\/JCP.v65n0803","article-title":"A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive\u2013compulsive disorder refractory to serotonin reuptake inhibitors","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2009.12.016","article-title":"Behavioural addictions in bipolar disorder patients: role of impulsivity and personality dimensions","volume":"125","author":"Di Nicola","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hup.1098","article-title":"Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome","volume":"25","author":"Di Nicola","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.pnpbp.2010.03.013","article-title":"Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction","volume":"34","author":"Di Nicola","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/JCP.0b013e31822c29a8","article-title":"Pregabalin augmentation in treatment-resistant obsessive\u2013compulsive disorder: a 16-week case series","volume":"31","author":"Di Nicola","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jad.2012.10.004","article-title":"Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature?","volume":"147","author":"Di Nicola","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib46","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1360-0443.2011.03546.x","article-title":"Compulsive features in behavioural addictions: the case of pathological gambling","volume":"107","author":"el-Guebaly","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2014.06.023_bib47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/npp.2009.185","article-title":"Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review","volume":"35","author":"Fineberg","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","article-title":"A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers","volume":"89","author":"Fong","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S1092852900016424","article-title":"Neuropsychological characteristics and personality traits in pathological gambling","volume":"13","author":"Forbush","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2014.06.023_bib50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1037\/a0026422","article-title":"Cognitive distortions as a component and treatment focus of pathological gambling: a review","volume":"26","author":"Fortune","year":"2012","journal-title":"Psychol. Addict. Behav."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2014.06.023_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-012-0323-x","article-title":"Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry","volume":"262","author":"Fountoulakis","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2014.06.023_bib52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eurpsy.2007.05.002","article-title":"Examining ventral and dorsal prefrontal function in bipolar disorder: a functional magnetic resonance imaging study","volume":"23","author":"Frangou","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1017\/S1355617706061091","article-title":"Self-reported and neuropsychological measures of impulsivity in pathological gambling","volume":"12","author":"Fuentes","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.jad.2014.06.023_bib54","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.v68n1108","article-title":"Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Furieri","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib56","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2014.06.023_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00004583-199802000-00009","article-title":"Double blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency","volume":"37","author":"Geller","year":"1998","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry."},{"key":"10.1016\/j.jad.2014.06.023_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.physbeh.2011.11.004","article-title":"Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems","volume":"106","author":"George","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib59","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/dot.1999.35.3.533849","article-title":"Quetiapine fumarate (Seroquel): a new atypical antipsychotic","volume":"35","author":"Goldstein","year":"1999","journal-title":"Drugs Today"},{"key":"10.1016\/j.jad.2014.06.023_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cogbrainres.2005.01.017","article-title":"Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls","volume":"23","author":"Goudriaan","year":"2005","journal-title":"Cogn. Brain Res."},{"key":"10.1016\/j.jad.2014.06.023_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib63","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","article-title":"Predicting response to opiate antagonists and placebo in the treatment of pathological gambling","volume":"200","author":"Grant","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges","volume":"69","author":"Grant","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","article-title":"Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study","volume":"212","author":"Grant","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","article-title":"Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study","volume":"197","author":"Grant","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","article-title":"A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers","volume":"75","author":"Grant","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib69","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0278-5846(01)00278-0","article-title":"Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions","volume":"26","author":"Guille","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.pnpbp.2004.05.040","article-title":"New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings","volume":"28","author":"Haldane","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1014292","article-title":"Treatment of pathological gambling with carbamazepine","volume":"27","author":"Haller","year":"1994","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib72","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib73","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the \u03b12\u03b4 ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jad.2014.06.023_bib74","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0740-5472(99)00080-X","article-title":"Divalproex sodium to treat concomitant substance abuse and mood disorders","volume":"18","author":"Hertzman","year":"2000","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.jad.2014.06.023_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1078345813486448","article-title":"Bupropion diversion and misuse in the correctional facility","volume":"19","author":"Hilliard","year":"2013","journal-title":"J. Correct. Health Care"},{"key":"10.1016\/j.jad.2014.06.023_bib76","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(10)62185-X","article-title":"Gambling disorders","volume":"378","author":"Hodgins","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2014.06.023_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000154478","article-title":"FDG-PET study in pathological gamblers. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism","volume":"58","author":"Hollander","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2014.06.023_bib79","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jad.2014.06.023_bib80","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.phrs.2005.05.012","article-title":"Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse","volume":"52","author":"Huguelet","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jad.2014.06.023_bib81","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.npp.1300917","article-title":"The effect of olanzapine on craving and alcohol consumption","volume":"31","author":"Hutchison","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib82","first-page":"e37306","article-title":"The neural basis of decision-making and reward processing in adults with euthymic bipolar disorder or attention-deficit\/hyperactivity disorder (ADHD)","volume":"7","author":"Ibanez","year":"2012","journal-title":"Public Libr. Sci. One"},{"key":"10.1016\/j.jad.2014.06.023_bib83","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/JCP.0b013e318150c841","article-title":"Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study","volume":"27","author":"Janiri","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib84","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/15622975.2011.585662","article-title":"Frontopolar cortical inefficiency may underpin reward and working memory dysfunction in bipolar disorder","volume":"13","author":"Jogia","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib85","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2014.06.023_bib86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ajmg.b.30900","article-title":"Convergent genome wide association results for bipolar disorder and substance dependence","volume":"150","author":"Johnson","year":"2009","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.jad.2014.06.023_bib87","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2014.06.023_bib88","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40263-013-0101-y","article-title":"Nalmefene: a review of its use in the treatment of alcohol dependence","volume":"27","author":"Keating","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2014.06.023_bib89","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.4088\/JCP.1206e17","article-title":"Long-term management strategies to achieve optimal function in patients with bipolar disorder","volume":"67","author":"Keck","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib90","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/070674371005500905","article-title":"Frequency and correlates of gambling problems in outpatients with major depressive disorder and bipolar disorder","volume":"55","author":"Kennedy","year":"2010","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2005.07.027","article-title":"Stroop performance in pathological gamblers","volume":"142","author":"Kertzman","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2007.06.026","article-title":"Go-no-go performance in pathological gamblers","volume":"161","author":"Kertzman","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib93","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1017\/S0033291708002900","article-title":"DSM-IV pathological gambling in the National Comorbidity Survey Replication","volume":"38","author":"Kessler","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2014.06.023_bib94","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2005.12.040","article-title":"Pathological gambling and mood disorders: clinical associations and treatment implications","volume":"92","author":"Kim","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib96","article-title":"Pharmaceutical treatment of bipolar depression: evidence from clinical guidelines and treatment recommendations","author":"K\u00f6hler","year":"2013","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jad.2014.06.023_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YCO.0b013e32831575d9","article-title":"Treatment of pathological gambling","volume":"22","author":"Leung","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib99","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers","volume":"163","author":"Leverich","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2550-7","article-title":"Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity","volume":"219","author":"Leeman","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib101","first-page":"507","article-title":"Clinical masks of bipolar disorders","volume":"55","author":"Lejoyeux","year":"2005","journal-title":"Rev. Prat."},{"key":"10.1016\/j.jad.2014.06.023_bib102","first-page":"5","article-title":"Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity","volume":"55","author":"Leysen","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biopsych.2010.03.038","article-title":"How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers","volume":"68","author":"Lloyd","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1360-0443.2010.03300.x","article-title":"Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys","volume":"106","author":"Lorains","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2014.06.023_bib105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.pbb.2011.09.010","article-title":"Novel glutamatergic agents for major depressive disorder and bipolar disorder","volume":"100","author":"Machado-Vieira","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib106","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalh\u00e3es","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"5 Suppl B","key":"10.1016\/j.jad.2014.06.023_bib107","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.18553\/jmcp.2012.18.s5-b.1","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"Maher","year":"2012","journal-title":"J. Managed Care Pharm."},{"key":"10.1016\/j.jad.2014.06.023_bib108","first-page":"347","article-title":"Preliminary analysis of genes involved in inflammatory, oxidative processes and CA2+signaling in bipolar disorder and comorbidity for substance use disorder","volume":"8","author":"Mandelli","year":"2011","journal-title":"Clin. Neuropsychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib109","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000330364","article-title":"Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome","volume":"45","author":"Mandelli","year":"2012","journal-title":"Psychopathology"},{"key":"10.1016\/j.jad.2014.06.023_bib110","first-page":"360","article-title":"Quetiapine in the treatment of pathological gambling associated with Bipolar Disorder","volume":"40","author":"Mannu","year":"2005","journal-title":"Riv. Psichiatr."},{"key":"10.1016\/j.jad.2014.06.023_bib111","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pscychresns.2007.03.003","article-title":"A functional MRI study of a paced motor activation task to evaluate frontal-subcortical circuit function in bipolar depression","volume":"155","author":"Marchand","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib112","first-page":"4","article-title":"Executive function abnormalities in pathological gamblers","volume":"27","author":"Marazziti","year":"2008","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2014.06.023_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2006.02.022","article-title":"Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm","volume":"93","author":"Maremmani","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1092852900027346","article-title":"Mood stabilizers in the treatment of substance use disorders","volume":"15","author":"Maremmani","year":"2010","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2014.06.023_bib115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-5618.2004.00111.x","article-title":"Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome","volume":"6","author":"Mart\u00ednez-Ar\u00e1n","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib116","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10826080701202429","article-title":"Alcohol protracted withdrawal syndrome: the role of anhedonia","volume":"43","author":"Martinotti","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jad.2014.06.023_bib117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0269881108089596","article-title":"Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs naltrexone","volume":"23","author":"Martinotti","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib118","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/0269881109102623","article-title":"Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial","volume":"24","author":"Martinotti","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib120","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.2174\/13816128113199990425","article-title":"The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview","volume":"19","author":"Martinotti","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2014.06.023_bib121","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.08m04369","article-title":"A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive\u2013compulsive disorder","volume":"70","author":"Matsunaga","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2008.08.019","article-title":"Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up","volume":"115","author":"Mazza","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib123","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0010-440X(96)90001-2","article-title":"Are impulse-control disorders related to bipolar disorder?","volume":"37","author":"McElroy","year":"1996","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2004.11.008","article-title":"Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?","volume":"86","author":"McElroy","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v69n0314","article-title":"Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial","volume":"69","author":"McElroy","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0376-8716(94)01062-P","article-title":"Introduction to the role of excitatory aminoacids in the actions of abused drugs: a symposium presented at the 1993 annual meeting of the College on Problems of Drug Dependence","volume":"37","author":"McGinty","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2014.06.023_bib127","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/hup.612","article-title":"Comorbidity in bipolar disorder: a framework for rational treatment selection","volume":"19","author":"McIntyre","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2006.12.005","article-title":"Problem gambling in bipolar disorder: results from the Canadian Community Health Survey","volume":"102","author":"McIntyre","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib129","first-page":"785","article-title":"Lithium and lady luck; use of lithium carbonate in compulsive gambling","volume":"80","author":"Moskowitz","year":"1980","journal-title":"N. Y. State. J. Med."},{"key":"10.1016\/j.jad.2014.06.023_bib130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4088\/JCP.v69n0808","article-title":"Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial","volume":"69","author":"Nejtek","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib131","first-page":"628","article-title":"Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder","volume":"41","author":"Nicolato","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib132","first-page":"194","article-title":"Amantadine in acute bipolar mania","volume":"41","author":"Ohlmeier","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib133","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-2008-1078748","article-title":"Amantadine reduces mania in borna disease virus-infected non-psychotic bipolar patients","volume":"41","author":"Ohlmeier","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib134","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","article-title":"Glutamatergic medications for the treatment of drug and behavioral addictions","volume":"100","author":"Olive","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.neuropharm.2011.03.010","article-title":"Natural rewards, neuroplasticity, and non-drug addictions","volume":"61","author":"Olsen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib136","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1517\/13543784.2012.685651","article-title":"Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence","volume":"21","author":"Oulis","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jad.2014.06.023_bib137","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1017\/S0033291711000316","article-title":"A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity","volume":"41","author":"Odlaug","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2014.06.023_bib138","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: a randomized single-blind study","volume":"63","author":"Pallanti","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib139","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000317286","article-title":"Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study","volume":"62","author":"Pallanti","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2014.06.023_bib140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","article-title":"Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group","volume":"2","author":"Pande","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib141","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00004714-200212000-00008","article-title":"Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?","volume":"22","author":"Perugi","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib142","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4088\/JCP.v66n0504","article-title":"Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"66","author":"Petry","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib143","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpsyt.2012.00102","article-title":"Amantadine in the treatment of pathological gambling: a case report","volume":"3","author":"Pettorruso","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib144","first-page":"109786","article-title":"Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives","author":"Pettorruso","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jad.2014.06.023_bib145","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.13090217","article-title":"Punding behavior in bipolar disorder type 1: a case report","author":"Pettorruso","year":"2014","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2014.06.023_bib146","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.psychres.2013.12.013","article-title":"Anhedonia in Parkinson\u2019s disease patients with and without pathological gambling: a case-control study","volume":"215","author":"Pettorruso","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2014.06.023_bib147","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200015050-00007","article-title":"Risperidone augmentation in refractory obsessive\u2013compulsive disorder: an open-label study","volume":"15","author":"Pfanner","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib148","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1755-5949.2010.00215.x","article-title":"Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders","volume":"17","author":"Post","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2014.06.023_bib149","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1098\/rstb.2008.0100","article-title":"The neurobiology of pathological gambling and drug addiction: an overview and new findings","volume":"363","author":"Potenza","year":"2008","journal-title":"Philos. Trans. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.jad.2014.06.023_bib150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10899-010-9199-8","article-title":"The prevalence and course of pathological gambling in the mood disorders","volume":"27","author":"Quilty","year":"2011","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.jad.2014.06.023_bib151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jad.2014.06.023_bib152","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2006.02.016","article-title":"A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder","volume":"93","author":"Robinson","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib153","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/FBP.0b013e3283305e7a","article-title":"Severity of gambling is associated with severity of depressive symptoms in pathological gamblers","volume":"20","author":"R\u00f8mer Thomsen","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib154","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/00048670903487282","article-title":"Pathological gambling and compulsive eating associated with aripiprazole","volume":"44","author":"Roxanas","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-5618.2006.00292.x","article-title":"Effects of lamotrigine in patients with bipolar disorder and alcohol dependence","volume":"8","author":"Rubio","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib156","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2014.06.023_bib157","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","article-title":"Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study","volume":"62","author":"Salloum","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib158","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11634390-000000000-00000","article-title":"The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence","volume":"26","author":"Sani","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2014.06.023_bib159","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.jcp.0000085417.08426.54","article-title":"Potential use of olanzapine in treatment of substance dependence disorders","volume":"23","author":"Sattar","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib160","first-page":"46S","article-title":"Valproate in the treatment of bipolar disorder and comorbid substance abuse: a 24-week open lable trial","volume":"61","author":"Sattar","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib161","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/da.21996","article-title":"Effects of aripiprazole augmentation in treatment-resistant obsessive\u2013compulsive disorder (a double blind clinical trial)","volume":"29","author":"Sayyah","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2014.06.023_bib500","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jad.2012.09.005","article-title":"An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder","volume":"147","author":"Schaffer","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib162","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs-in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib163","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1901\/jeab.2009.92-1","article-title":"Probability discounting of gains and losses: implications for risk attitudes and impulsivity","volume":"92","author":"Shead","year":"2009","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.jad.2014.06.023_bib165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jad.2014.06.023_bib166","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euroneuro.2006.07.002","article-title":"Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive\u2013compulsive disorder: a meta-analysis of the randomized controlled trials","volume":"17","author":"Skapinakis","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib167","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjp.bp.110.084996","article-title":"Pathological gambling and the treatment of psychosis with aripiprazole: case reports","volume":"199","author":"Smith","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib168","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3399\/bjgp12X653516","article-title":"Substance misuse of gabapentin","volume":"62","author":"Smith","year":"2012","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.jad.2014.06.023_bib169","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/S1516-44462010000400029","article-title":"Mania switch induced by amantadine in bipolar disorder: report of three cases","volume":"32","author":"Sodr\u00e9","year":"2010","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jad.2014.06.023_bib170","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1530-0277.2010.01270.x","article-title":"A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence","volume":"34","author":"Stedman","year":"2010","journal-title":"Alcoholism: Clin. Exp. Res."},{"key":"10.1016\/j.jad.2014.06.023_bib171","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-6632.2009.05146.x","article-title":"The strong relationship between bipolar and substance-use disorder","volume":"1187","author":"Swann","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2014.06.023_bib173","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jad.2014.06.023_bib174","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jad.2014.06.023_bib175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-5618.2011.00973.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report","volume":"14","author":"Tolliver","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib176","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ph6020251","article-title":"NMda receptor modulators in the treatment of drug addiction","volume":"6","author":"Tomek","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jad.2014.06.023_bib177","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1441.018","article-title":"Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify \u201cconnectivity constellation\u201c and drug target genes with pleiotropic effects","volume":"1141","author":"Uhl","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2014.06.023_bib178","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1874473711205010003","article-title":"Evidence-based pharmacological treatment of substance use disorders and pathological gambling","volume":"5","author":"van den Brink","year":"2012","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.jad.2014.06.023_bib179","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/alcalc\/agt061","article-title":"Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies","volume":"48","author":"van den Brink","year":"2013","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.jad.2014.06.023_bib180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-012-2854-2","article-title":"Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania","volume":"225","author":"van Enkhuizen","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib181","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2009.07.007","article-title":"Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling","volume":"34","author":"van Holst","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2014.06.023_bib182","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0924-9338(00)00514-9","article-title":"Adjunctive gabapentin treatment of bipolar disorder","volume":"15","author":"Vieta","year":"2000","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib183","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004714-200208000-00017","article-title":"Use of topiramate in treatment-resistant bipolar spectrum disorders","volume":"22","author":"Vieta","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib184","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4088\/JCP.v67n0320","article-title":"A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder","volume":"67","author":"Vieta","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib185","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11920-009-0075-0","article-title":"A critical update on psychological interventions for bipolar disorders","volume":"11","author":"Vieta","year":"2009","journal-title":"Curr. Psychiatry Rep."},{"issue":"Suppl 7","key":"10.1016\/j.jad.2014.06.023_bib186","first-page":"24","article-title":"Management of comorbid bipolar disorder and substance abuse","volume":"67","author":"Vornik","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.06.023_bib187","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1046\/j.1460-9568.2003.02922.x","article-title":"Neuronal activity in primate dorsolateral and orbital prefrontal cortex during performance of a reward preference task","volume":"18","author":"Wallis","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jad.2014.06.023_bib188","first-page":"5","article-title":"Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study","volume":"43","author":"Wang","year":"2010","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2014.06.023_bib189","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-011-2634-4","article-title":"Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics","volume":"222","author":"Wasserman","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00023210-200620030-00004","article-title":"Study Group. Extended-release carbamazepine capsules as monotherapy in bipolar disorder: pooled results from two randomised, double-blind, placebo-controlled trials","volume":"20","author":"Weisler","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2014.06.023_bib191","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-5618.2009.00665.x","article-title":"Neurocognitive impairment in bipolar disorder patients: functional implications","volume":"11","author":"Wingo","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2014.06.023_bib192","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1024203403982","article-title":"Treatment issues pertaining to pathological gamblers with a comorbid disorder","volume":"19","author":"Winters","year":"2003","journal-title":"J. Gambl. Stud."},{"key":"10.1016\/j.jad.2014.06.023_bib193","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.06.023_bib194","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.npp.1301295","article-title":"A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers","volume":"32","author":"Zack","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.06.023_bib195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/JCP.0b013e3181e7810a","article-title":"Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis","volume":"30","author":"Zhornitsky","year":"2010","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271400384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T18:27:12Z","timestamp":1649442432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271400384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":194,"alternative-id":["S016503271400384X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.06.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bipolar disorder and gambling disorder comorbidity: Current evidence and implications for pharmacological treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}